Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
Open Access
- 22 March 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (12) , 816-821
- https://doi.org/10.1056/nejm199003223221205
Abstract
To compare ondansetron (GR 38032F), a 5-hydroxytryptamine3-receptor antagonist, with metoclopramide in the prophylaxis of acute cisplatin-induced emesis, we conducted a double-blind crossover study in 97 patients scheduled to receive cisplatin (80 to 100 mg per square meter of body-surface area) for treatment of cancer. None had received chemotherapy before this trial.This publication has 21 references indexed in Scilit:
- Phase II Trials of the Serotonin Antagonist GR38032F for the Control of Vomiting Caused by CisplatinJNCI Journal of the National Cancer Institute, 1989
- The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694British Journal of Cancer, 1988
- Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.Journal of Clinical Oncology, 1988
- Antiemetic properties of the 5HT3-receptor antagonist, gr38032fCancer Treatment Reviews, 1987
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.BMJ, 1986
- Extrapyramidal reactions with metoclopramide.BMJ, 1985
- Emesis due to cancer chemotherapy: Results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomitingEuropean Journal of Cancer and Clinical Oncology, 1984
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Blockade of neuronal tryptamine receptors by metoclopramideEuropean Journal of Pharmacology, 1978